A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers

Clinical trial NCT05238207 · TERMINATED

Trial details

NCT number: NCT05238207
Sponsor: Bond Biosciences
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hereditary Hemochromatosis

Start date: 2022-03-28
Primary completion: 2023-05-04
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.